XML 22 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814
FAIR VALUE MEASUREMENTS (Details 2) - Level 3 - Contingent consideration
$ in Thousands
9 Months Ended
Sep. 30, 2015
USD ($)
Level 3 measurements  
Balance at beginning of the period $ (11,691)
BioRx acquisition (41,000)
Changes in fair value 1,660
Payments 6,750
Balance at end of the period $ (44,281)